Market Scenario
The Dental Infection Treatment Market is expected to reach USD 23,500 Million by 2030 at 9.6% CAGR during the forecast period 2022-2030, estimates Market Research Future (MRFR). The market for dental infection treatment is on a constant rise due to poor dental hygiene, sedentary lifestyles, lack of dental health awareness, and absence of flossing. High sugar diet and junk foods cause dental infection, whereas consumption of sodas lead to rise in cavities due to the weakening of the natural physical barrier of the teeth. Moreover, advancements in technologies and reimbursement for medicines also boost the market growth and will continue to do so in the coming years. Also, consumption of some medical drugs like anti-depressants and blood pressure medicines cause dental infection, which increases the demand for dental infection treatment market .
The market for dental infection treatment is highly fragmented due to large number of players especially in the drugs segment which has put pressure on the profit margin, rise of low quality and low cost drug products manufactured by companies operating from regions with poor regulatory framework which reduces the market of quality drug products. Also the market for dental infection treatment is highly dependent on product development strategy such as high quality fills and cements. The drug segment is growing at a slow pace due to saturation of the market. Considering all these factors
Key Players
The key players in the dental infection treatment market are Kerr Corporation, Patterson Dental Supply, Inc., Henry Schein, Inc., Taj Pharmaceuticals Limited, Septodont Healthcare India Pvt. Ltd., Bayer HealthCare, Ultradent Products Inc., and Bristol-Myers Squibb and many more.
Market Segmentation
The global dental infection treatment market is segmented into by type, treatment, and end users. The By type, segment of the market is segmented into periapical abscess, periodontal abscess, and others. Conditions like such as bruxism, occlusal overload, and rise in diabetes which predisposes a patient to the formation of periodontal abscess, lead to can drive the growth of periodontal abscess treatment market segment.
Various forms of treatments are drugs, which are antibiotics or pain killers, and procedures such as root canal, tooth fillings, tooth extraction, dental implant tools and many more others. Root canal procedures are pain-free, efficient, cost-effective and are long lasting, these factors drive the appeal for root canal treatment among patients, in turn fuelling the growth of root canal treatment market. On the other hand, demand for tooth extraction treatments is on the rise due to the facilitation of orthodontic treatment surgery, and reduced cost compared to other treatments.
The End users of in the dental infection treatment market are dentistry clinics, hospitals, and others.
Regional Analysis
Geographically, the dental infection treatment market is geographically segmented into North America, Europe, Asia -Pacific (APAC), and the Middle-East and Africa.
Among all regions, the United States (U.S) in North America holds the maximum market share due to extensive use of medications and greater expenditure on healthcare. Emergence of new technology technologies and devices in the U.S. also drives the market for global dental infection treatment. The presence of large device companies helps to establish the dental infection treatment market in this region. This region is hugely lucrative for manufacturers in the dental infection treatment market owing to a large consumer base. Also In addition, growing number of emergency rooms (ER) for dental care, ability to afford dental treatment services, and increasing per capita can enhance the demand for dental infection treatment market in this region.
On the other hand, after North America, Europe is the largest market owing to sizeable disposable income coupled with rising awareness about dental health hazards. Also, easy access to dental care services and increasing number of dental clinics and infrastructure help establish the can allow players to penetrate the market in this region easily.
The Middle East & and Africa dental infection treatment market is governed by the Gulf nations such as Saudi Arabia and the United Arab Emirates (UAE). Advancements in technology like non-invasive treatments in dentistry, growing cases of detrimental dental health due to cavity, and constant research and developments to enhance the dental infection treatment experience can drive the market growth in this region.
